(Q33941948)

30 July 2017

1 reference

title

The role of carnitine supplementation during valproic acid therapy (English)

1 reference

30 July 2017

J Y Raskind

1

1 reference

30 July 2017

G M El-Chaar

series ordinal

2

1 reference

30 July 2017

language of work or name

English

0 references

publication date

1 May 2000

1 reference

Annals of Pharmacotherapy

30 July 2017

published in

1 reference

30 July 2017

volume

34

1 reference

30 July 2017

issue

5

1 reference

30 July 2017

page(s)

630-638

1 reference

Drug therapy: Valproic acid

30 July 2017

cites work

1 reference

Valproic acid hepatic fatalities. II. US experience since 1984.

21 January 2018

1 reference

Carnitine, valproate, and toxicity

21 January 2018

1 reference

l-Carnitine. A preliminary review of its pharmacokinetics, and its therapeutic use in ischaemic cardiac disease and primary and secondary carnitine deficiencies in relationship to its role in fatty acid metabolism

21 January 2018

1 reference

l-Carnitine Supplementation in Childhood Epilepsy: Current Perspectives

21 January 2018

1 reference

Diet- and valproate-induced transient hyperammonemia: effect of L-carnitine.

21 January 2018

1 reference

Serum carnitine during valproic acid therapy

21 January 2018

1 reference

Effect of L-carnitine supplementation on acute valproate intoxication

21 January 2018

1 reference

Valproate therapy does not deplete carnitine levels in otherwise healthy children.

21 January 2018

1 reference

Severe hepatotoxicity during valproate therapy: an update and report of eight new fatalities.

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1345/APH.19242

1 reference

30 July 2017

1 reference